Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 69,579

Sort by:

Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome ) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome ) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy S...

May 2022 37 pages

Multiple Organ Failure (Multiple Organ Dysfunction Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Multiple Organ Failure (Multiple Organ Dysfunction Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Multiple Organ Failure (Multiple Organ Dysfunction...

May 2022 38 pages

Muscarinic Acetylcholine Receptor M1 (CHRM1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Muscarinic Acetylcholine Receptor M1 (CHRM1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Muscarinic Acetylcholine Receptor M1 (CHRM1)...

May 2022 64 pages

Muscarinic Acetylcholine Receptor M3 (CHRM3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Muscarinic Acetylcholine Receptor M3 (CHRM3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Muscarinic Acetylcholine Receptor M3 (CHRM3)...

May 2022 57 pages

Muscle Atrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Muscle Atrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Muscle Atrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players pr...

May 2022 40 pages

Muscle Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Muscle Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Muscle Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...

May 2022 39 pages

Muscle Invasive Bladder Cancer (MIBC) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Muscle Invasive Bladder Cancer (MIBC) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Muscle Invasive Bladder Cancer (MIBC) Drugs in Development by Stages, Targ...

May 2022 72 pages

Muscle Spasm Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Muscle Spasm Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Muscle Spasm Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...

May 2022 35 pages

Muscle Spasticity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Muscle Spasticity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Muscle Spasticity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 64 pages

Muscle Wasting Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Muscle Wasting Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Muscle Wasting Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...

May 2022 57 pages

Musculoskeletal Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Musculoskeletal Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Musculoskeletal Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...

May 2022 107 pages

Myalgia (Muscle Pain) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Myalgia (Muscle Pain) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Myalgia (Muscle Pain) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...

May 2022 37 pages

Mycobacterium avium Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Mycobacterium avium Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Mycobacterium avium Infections Drugs in Development by Stages, Target, MoA, RoA,...

May 2022 42 pages

Mycobacterium Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Mycobacterium Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Mycobacterium Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...

May 2022 298 pages

Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secretory Antigenic Target or esxA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secretory Antigenic Target or esxA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players S...

May 2022 35 pages

Mycobacterium Tuberculosis Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Mycobacterium Tuberculosis Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Mycobacterium Tuberculosis Infections Drugs in Development by Stages, Targ...

May 2022 267 pages

Mycobacterium tuberculosis Protein Ag85A Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Mycobacterium tuberculosis Protein Ag85A Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Mycobacterium tuberculosis Protein Ag85A Drugs i...

May 2022 36 pages

Mycosis Fungoides Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Mycosis Fungoides Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Mycosis Fungoides Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 70 pages

Myelofibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Myelofibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Myelofibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...

May 2022 113 pages

Myeloperoxidase (MPO or EC 1.11.2.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Myeloperoxidase (MPO or EC 1.11.2.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Myeloperoxidase (MPO or EC 1.11.2.2) Drugs in Develo...

May 2022 35 pages

Myeloproliferative Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Myeloproliferative Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Myeloproliferative Disorders Drugs in Development by Stages, Target, MoA, RoA, Mole...

May 2022 167 pages

Myopia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Myopia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Myopia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overvi...

May 2022 46 pages

Myotonic Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Myotonic Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Myotonic Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 74 pages

Myxoid Liposarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Myxoid Liposarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Myxoid Liposarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 43 pages

Na+-K+ Exchanging ATPase (Sodium Potassium ATPase or Sodium Potassium Pump or EC 7.2.2.13) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Na+-K+ Exchanging ATPase (Sodium Potassium ATPase or Sodium Potassium Pump or EC 7.2.2.13) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMAR...

May 2022 41 pages

NAD+ ADP Ribosyltransferase (Poly Adenosine Diphosphate Ribose Polymerase or PARP or EC 2.4.2.30) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

NAD+ ADP Ribosyltransferase (Poly Adenosine Diphosphate Ribose Polymerase or PARP or EC 2.4.2.30) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players...

May 2022 103 pages

NADH Ubiquinone Oxidoreductase Chain 1 (NADH Dehydrogenase Subunit 1 or MT-ND1 or EC 7.1.1.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

NADH Ubiquinone Oxidoreductase Chain 1 (NADH Dehydrogenase Subunit 1 or MT-ND1 or EC 7.1.1.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUM...

May 2022 36 pages

NADPH Oxidase (NOX or EC 1.6.3.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

NADPH Oxidase (NOX or EC 1.6.3.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY NADPH Oxidase (NOX or EC 1.6.3.1) Drugs in Development...

May 2022 68 pages

Natural Killer Cell Lymphomas Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Natural Killer Cell Lymphomas Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Natural Killer Cell Lymphomas Drugs in Development by Stages, Target, MoA, RoA, Mo...

May 2022 98 pages

Nausea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Nausea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Nausea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overvi...

May 2022 45 pages

Necrotizing Enterocolitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Necrotizing Enterocolitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Necrotizing Enterocolitis Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 41 pages

Neisseria Gonorrhoeae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Neisseria Gonorrhoeae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Neisseria Gonorrhoeae Infections Drugs in Development by Stages, Target, MoA, R...

May 2022 65 pages

Neonatal Respiratory Distress Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Neonatal Respiratory Distress Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Neonatal Respiratory Distress Syndrome Drugs in Development by Stages, Ta...

May 2022 39 pages

Nerve Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Nerve Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Nerve Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...

May 2022 55 pages

Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Netherton Syndrome (Trichorrhexis Invaginata, Bamboo...

May 2022 42 pages

Neuroendocrine Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Neuroendocrine Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Neuroendocrine Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...

May 2022 173 pages

Neuroendocrine Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Neuroendocrine Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Neuroendocrine Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...

May 2022 52 pages

Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) Dr...

May 2022 59 pages

Neurogenic Locus Notch Homolog Protein 1 (Translocation Associated Notch Protein TAN 1 or NOTCH1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Neurogenic Locus Notch Homolog Protein 1 (Translocation Associated Notch Protein TAN 1 or NOTCH1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players...

May 2022 38 pages

Neuroinflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Neuroinflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Neuroinflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 88 pages

Neuromuscular Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Neuromuscular Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Neuromuscular Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 74 pages

Neuronal Acetylcholine Receptor Subunit Alpha 3 (CHRNA3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Neuronal Acetylcholine Receptor Subunit Alpha 3 (CHRNA3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Neuronal Acetylcholine Receptor...

May 2022 35 pages

Neuronal Acetylcholine Receptor Subunit Beta 4 (CHRNB4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Neuronal Acetylcholine Receptor Subunit Beta 4 (CHRNB4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Neuronal Acetylcholine Receptor S...

May 2022 36 pages

Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides a...

May 2022 85 pages

Neurotensin Receptor Type 1 (NTR1 or High Affinity Levocabastine Insensitive Neurotensin Receptor or NTRH or NTSR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Neurotensin Receptor Type 1 (NTR1 or High Affinity Levocabastine Insensitive Neurotensin Receptor or NTRH or NTSR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Ty...

May 2022 35 pages

Nicotinamide N Methyltransferase (NNMT or EC 2.1.1.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Nicotinamide N Methyltransferase (NNMT or EC 2.1.1.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Nicotinamide N Methyltransferase (N...

May 2022 38 pages

Nicotine Addiction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Nicotine Addiction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Nicotine Addiction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 57 pages

Niemann Pick C1 Like Protein 1 (NPC1L1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Niemann Pick C1 Like Protein 1 (NPC1L1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Niemann Pick C1 Like Protein 1 (NPC1L1) Drugs in...

May 2022 41 pages

Niemann Pick C1 Protein (NPC1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Niemann Pick C1 Protein (NPC1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Niemann Pick C1 Protein (NPC1) Drugs in Development by The...

May 2022 35 pages

Nitric Oxide Synthase (NO Synthase or NOS or EC 1.14.13.39) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Nitric Oxide Synthase (NO Synthase or NOS or EC 1.14.13.39) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Nitric Oxide Synthase (NO Syn...

May 2022 56 pages

Filters

Clear all

Price

—

Date

—

Pages

—

Offers

33% OFF on “TCR-Based Antibody a...

Discount Offer from GMD Research

280

Special Offer from MP Advisors

Special Offer on Therapy Class R...